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1111-209 A Novel Method to Assess Ventricular Contraction 
Dyssynchrony by Tissue Synchrony Index
Jing Ping Sun, Ed Chinchoy, Deborah A. Agler, Craig R. Asher, George Perlic, Kathleen 
Kassimatis, Neil L. Greenberg, Bruce L. Wilkoff, James D. Thomas, Richard A. Grimm, 
The Cleveland Clinic Foundation, Twinsburg, OH
Background: Biventricular pacing (CRT) has been shown to improve symptoms and
exercise capacity in patients with heart failure and a wide QRS complex. Criteria for
patient selection and lead positioning are essential for achieving clinical benefit.
Methods and Results: Twenty-eight patients (20 males, 66±11 years) with ischemic and
nonischemic cardiomyopathy and NYHA class III to IV heart failure and QRS duration
>140 ms receiving CRT were assessed before and after pacing. Tissue Doppler echocar-
diography was performed using a 4-basal, 4-mid segmental model (4-and 2-chamber) to
assess the time to peak systolic velocity (TS), and the time to peak myocardial displace-
ment (TPMD).
The septal posterior wall delay (SPWD) was measured by M-mode at the base in the
parasternal long axis view. Tissue synchrony index (TSI) was used to show the ventricu-
lar segmental contraction delay. Patients with LBBB exhibited 3 different patterns of delay
by TSI including delay involving the apical septal (n=5), the basal and mid inferior (n=4)
and the basal lateral wall (n=16). Patients with RBBB demonstrated delay involving the
septum (n=3). The standard deviation of time to TS and TPMD between segments was
used as an index of synchronization. There was significant improvement of TSI after pac-
ing.
Conclusions: TSI is a new index, which provides rapid visualization ofventricular con-
traction dyssynchrony, providing a potentially useful method for selection of patients and
for implant pacing lead localization.
1111-210 The Predictive Value of QRS Duration as a Marker of 
Ventricular Dyssynchrony
Justin Ghosh, Simon Thackray, Ramesh DeSilva, Sarah Hurren, Gerald C. Kaye, John G 
F Cleland, University of Hull, Kingston upon Hull, United Kingdom
Background: Cardiac resynchronisation therapy (CRT) is becoming widely used in the
management of advanced cardiac failure due to systolic dysfunction and ventricular dys-
synchrony. QRS prolongation is used as a surrogate marker of dyssynchrony, but not all
patients with QRS prolongation benefit from CRT. A reason may be that QRS prolonga-
tion and ventricular dyssynchrony are not closely related.
Aim: To correlate QRS prolongation with an echocardiographic indicator of ventricular
dyssynchrony –aortic pre-ejection delay (APED).
Methods : 153 patients with symptomatic heart failure and left ventricular systolic dys-
function were retrospectively analysed. Adequate data was collected from 118 patients.
QRS duration was measured automatically (MAC 1200 - Marquette). APED, measured
as time from the onset of QRS to the onset of aortic forward flow using pulsed wave Dop-
pler above the level of the aortic valve (Echopac 6.2 GE Vingmed ), the mean value from
3 beats being recorded. Poor quality ECG recording with the doppler signal accounted for
the majority of inadequate data, and excluded patients.
Results: Baseline characteristics: Age 73.1(SD 7.3), NYHA class II(73), III(37), IV (8),
mean ejection fraction 29.4% (SD 9.5),35% of all subjects had a QRS duration > 120ms.
The correlation between the QRS duration and the APED was only moderate ( Pearson
correlation 0.47,p=0.001). The correlation was higher in patients with QRS>120
(R=0.67,p=0.001) and lower in patients with a QRS <=120ms (R=0.08, p=n/s)
Conclusion: QRS duration and APED have only a modest association. The correlation is
stronger in those with significant QRS prolongation. There is a poor correlation below a
QRS duration of 120ms. This suggests that using QRS prolongation as a sole indicator of
dyssynchrony may exclude a number of heart failure patients with a demonstrable
marker of echocardiographic dyssynchrony. The data does not however indicate if such
patients would respond to CRT
1111-211 Narrowing of the Widest QRS Predicts Improvement in 
Functional Class and Echocardiographic Parameters in 
Patients With Cardiac Resynchronization Therapy 
Devices
John D. Burkhardt, Yaariv Khaykin, George Joseph, Kenneth Ng, Navin Kedia, Richard 
Grimm, Patrick Tchou, Bruce L. Wilkoff, Cleveland Clinic Foundation, Cleveland, OH
Few parameters have been shown to predict improvement in patients treated for conges-
tive heart failure (CHF) with cardiac resynchronization therapy (CRT). To assess whether
narrowing of the QRS duration after CRT device implantation predicts improvement in
clinical and echocardiographic parameters we collected these data for 145 consecutive
patients treated with CRT at the Cleveland Clinic Foundation between 09/01/1998 and
02/01/2002 (age 66±13 years, 68% male, 63% ischemic cardiomyopathy). All patients
had pre and post implantation 12-lead ECG and 2D-echocardiograms. Widest QRS in
any lead before and after CRT was documented. Functional status was assessed during
follow-up at the CHF clinic. QRS narrowed significantly with CRT from 187.2+/- 30.7
msec to 179.4 +/- 24.8 msec ( p< 0.007). In patients who experienced QRS narrowing
with CRT, NYHA functional class, left ventricular end diastolic dimension (LVEDD), and
mitral regurgitation (MR) improved significantly versus patients in whom the widest QRS
did not narrow. There was a strong trend towards improvement in the left ventricular end
systolic dimension (LVESD) and ejection fraction (EF) in those with narrowed QRS. Con-
clusion: Narrowing of the widest QRS complex after CRT device implantation predicts
improvement in NYHA functional class, left ventricular end diastolic dimension and mitral
regurgitation. 
1111-212 Left Ventricular Asynchrony Predicts Heart Failure 
Progression After Cardiac Resynchronization Therapy
Maria V. Pitzalis, Massimo Iacoviello, Roberta Romito, Pietro Guida, Giovanni Luzzi, 
Stefania Greco, Cinzia Forleo, Brian Rizzon, Elisabetta De Tommasi, Luigi Di Biase, 
Paolo Rizzon, Bari, Italy
Echocardiographic evaluation of left ventricular asynchrony (LVA) has been shown to pre-
dict hemodynamic improvement after cardiac resynchronization therapy (CRT).
To test the role of LVA in predicting heart failure (HF) progression after CRT, we studied
44 patients (63±11 years, 23 male) with HF (9 with ischemic cardiomyopathy), NYHA
class III, left bundle branch block (LBBB), in optimal medical therapy who underwent
CRT. Before pacemaker implantation, LVA was evaluated by calculating QRS duration
(168±18 ms) at ECG and septal to posterior wall motion delay, SPWMD (157±96 ms), at
echocardiography; left ventricular end-diastolic diameter (LVEDD, 67±6 mm), left ventric-
ular ejection fraction (LVEF, 25±6%) and mitral regurgitation (MR, 2.6±0.9 a.u.) were also
evaluated.
During follow-up (13±9 months) 9 patients experienced HF progression (1 needed a sta-
ble increase of diuretic therapy, 6 were hospitalized and 3 died after worsening of HF).
Among studied variables only SPWMD (p=0.02) and ischemic cardiomyopathy (p=0.02)
were significantly related to events at univariate analysis. The Figure shows the Kaplan-
Meier curves of patients with SPWMD above and below the median value.
In conclusion, in patients with severe HF and LBBB, the absence of a marked LVA at
echocardiography is associated to the occurrence of HF progression after CRT, thus
strengthening its role in predicting patients who will benefit from biventricular pacing. 
1111-223 Left Ventricular Reverse Remodeling Predicted 
Rehospitalization for Heart Failure After Cardiac 
Resynchronization Therapy
Cheuk-Man Yu, Jeffrey Wing-Hong Fung, Qing Zhang, Chi-Kin Chan, Shun-Ling Kong, 
Hong Lin, Yat-Sun Chan, Yan Zhang, Gabriel WK Yip, Leo CC Kum, Eugene B. Wu, John 
E Sanderson, The Chinese University of Hong Kong, Hong Kong, Hong Kong
Background:Cardiac resynchronization therapy (CRT) has been shown recently to
improve heart failure (HF) rehospitalization. It is also benefit the heart by inducing left
ventricular (LV) reverse remodeling. This study investigated if responders of reverse
remodeling were able to predict a lower rehospitalization event rate.
Methods: 53 patients (aged 65±11years, 66% male, 58% non-ischemic etiology)
received CRT were prospectively studied. Echocardiography and clinical assessment
were performed at baseline and 3-month follow up to assess LV reverse remodeling
response. Responders were define as a reduction of LV end-systolic volume >15%.
Results: The mean duration of follow up was 753±386 days. Responders of reverse
remodeling were observed in 57% of patients, whereas the rest were classified as non-
responders (43%). Mortality occurred in 17% of patients, while HF developed in 13% of
patients. The responders had a significantly lower rate of developing HF than non-
responders (3% Vs 12%, Log Rank Chi2=4.16, p<0.05). There was also a trend towards
lower mortality rate for responders than non-responders, though it was not significant
(13% Vs 22%). The responders also had a greater improvement of New York Heart Asso-
ciation class (-1.04±0.5 Vs -0.5±0.6, p=0.01) and peak exercise capacity (1.1±1.6 Vs -
 TS(msec) TPMD (msec) SPWD (msec)
Sinus 44±16 74±25 141±103
Pacing 35±16 47±29 48±50
p 0.03 0.0007 0.001
Parameter Patients with narrowed 
QRS
Patients without 
narrowed QRS
P value
NYHA improvement, % 51% 33% 0.04
LVEDD decreased, % 78% 55% 0.004
LVESD decreased, % 72% 56% 0.06
MR Decreased, % 60% 42% 0.04
EF Improved, % 28% 16% 0.11
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0.2±1.2 METs, p<0.05).
Conclusions: Responders of LV reverse remodeling predicts a lower heart failure event
rate than non-responders. They were also associated with more symptomatic improve-
ment and a better gain in peak exercise capacity.
1111-224 Improvement of Brain Natriuretic Peptide Levels 48 
Hours Following Cardiac Resynchronization Therapy
Nazim U. Khan, David W. Frazier, Srivani R. Ambati, Jaafer Golzar, Martha Clutter, Paul 
W. Vos, Harry J. DeAntonio, Assad Movahed, East Carolina University, Brody School of 
Medicine, Greenville, NC
Background: Brain natriuretic peptide (BNP) levels are a marker of left ventricular dys-
function in heart failure. High BNP levels after optimal medical management of heart fail-
ure are an independent predictor of prognosis. Cardiac resynchronization therapy (CRT)
or dual ventricular chamber pacing improves quality of life, exercise capacity and cardiac
function. A small previous study showed improvement in BNP levels with chronic CRT
(15±8 weeks). We investigated the short term effects of CRT on BNP levels.
Methods: 36 patients with a mean EF 23±7% and LBBB (mean QRS 170±25ms) were
investigated. BNP levels were checked immediately prior to and 48 hours after CRT. BNP
levels were measured using the Triage BNP test/ Biosite Diagnostics, USA.
Results: The paired t-test on the log transformed data indicates that the difference
between baseline BNP and 48 hours BNP is statistically significant (p=0.0006). The aver-
age change on the log scale is –0.3956 which is 0.673 when converted to a proportion.
The 95% confidence interval for the average change is 0.545-0.832. The figure shows
the ratios of 48 hours/baseline BNP levels plotted in increasing order of the ratio, for the
36 patients. 75% of the patients had a reduction in BNP.
Conclusions: There is a statistically significant reduction in BNP levels 48 hours follow-
ing CRT. 
1111-225 In the Rapid Pacing Canine Model of Heart Failure, Left 
Ventricular Stimulation Resynchronizes Better the Left 
Ventricle Compared to Biventricular or Right Ventricular 
Stimulation: An Echocardiographic-Hemodynamic 
Correlation of Systolic and Diastolic Function
Bernard Thibault, Anique Ducharme, Yan-Fen Shi, Marc Dubuc, Peter Guerra, Laurent 
Macle, Denis Roy, Mario Talajic, Jean-Claude Tardif, Institut de Cardiologie de Montréal, 
Montreal, PQ, Canada
Resynchronization therapy is effective for patients with left ventricle (LV) dysfunction, but
the underlying mechanisms are not well understood. We studied acute hemodynamic
effects of RV, LV and biventricular (BiV) and established the correlation with LV resyn-
chronization assessed with echocardiography and tissue Doppler. Methods: A total of 17
dogs were paced at high rate for a minimum of 4 weeks to create LV dysfunction. Trans-
venous pacing electrodes were implanted in the right atrium, the right ventricle (RV) and
in a lateral branch of the coronary sinus (LV). Aortic, LV and pulmonary pressure were
continuously monitored and because dogs have short PR intervals, complete AV node
ablation was performed to assess the isolated effect of the different modes of stimulation,
with no participation of intrinsic conduction. Results: All the animals developed severe
heart failure (mean LVEF=28,7%), none with a wide QRS. LV stimulation was associated
with better LV hemodynamic parameters than BiV (5-10%)which was superior to RV stim-
ulation (10-20%, p<0.05). Echocardiographic evaluation showed that LV pacing was
associated with improved LVEF, less mitral regurgitation (MR) and less LV intraventricular
dyssynchrony as assessed with tissue Doppler. Improved systolic performance was
associated with improved diastolic performance (negative Lvdpdt) and diastolic pattern
assessed by echo. Conclusions: 1- In a canine model of heart failure, LV stimulation was
found to result in better LV systolic and diastolic performance compared to BiV and RV
stimulation. 2- The superior LV performance with LV pacing is associated with improved
LVEF, less mitral regurgitation and less intraventricular systolic and diastolic LV dyssyn-
chrony.
1111-226 Frequency and Mechanisms of Inappropriate 
Implantable Cardioverter Defibrillator Therapy in MADIT 
II
James P. Daubert, Wojciech Zareba, David S. Cannom, Claudio D. Schuger, Paul Wang, 
Mark L. Andrews, Jackson Hall, Arthur J. Moss, University of Rochester Medical Center, 
Rochester, NY
Background: Inappropriate implantable defibrillator (ICD) shocks have been reported to
be a common adverse event in ICD patients, with serious consequences including
impaired quality of life. Methods: We classified the rhythm triggering ICD therapy by
review of stored electrograms for each episode. Inappropriate therapy was defined as
antitachycardia pacing or ICD shock for anything other than ventricular arrhythmia. Inap-
propriate shocks were further classified as atrial fibrillation (AF), other supraventricular
tachycardia (SVT) (including sinus), or abnormal sensing. We examined the baseline
clinical characteristics and medications of patients with and without inappropriate shocks.
Results: Inappropriate shocks occurred in 88 (12.2 %) of the 720 patients who received
an ICD in MADIT II. A total of 806 therapies were delivered from the ICD of which 513
(63.6%) were appropriate and 293 (36.4%) were inappropriate. The clinical characteris-
tics of patients receiving inappropriate therapy were not different from those patients not
receiving such therapy. Conclusions: Despite awareness of the frequency of inappropri-
ate therapy in prior ICD trials, and despite frequent use of detection algorithms, inappro-
priate ICD therapy was common in the MADIT II trial. The most common mechanism for
inappropriate shocks in the MADIT II trial was AF. Clinical characteristics and medica-
tions prescribed do not predict which patients experience inappropriate ICD therapy.
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828-1 Pulmonary Vein Isolation to Prevent Atrial Fibrillation: 
Long-Term Safety, Efficacy, and Predictors of Outcome
Hakan Oral, Aman Chugh, Burr W. Hall, Peter Cheung, Srikar Veerareddy, Kristina 
Lemola, Jihn Han, Kamala Tamirisa, Frank Pelosi, Jr., Fred Morady, University of 
Michigan, Ann Arbor, MI
Background: The long-term safety and efficacy of segmental ostial ablation to isolate
the pulmonary veins in patients with atrial fibrillation (AF) have not been well-
defined.Methods and Results: Pulmonary vein isolation by ostial applications of radiof-
requency energy guided by pulmonary vein potentials was performed in 187 consecutive
patients (mean age = 52 ± 11 years) with paroxysmal (167) or persistent AF (20). The left
superior, left inferior, and right superior pulmonary veins were targeted in all patients, and
the right inferior pulmonary vein also was targeted in 73 patients (39%). Successful isola-
tion was achieved in 96% of targeted pulmonary veins. A repeat ablation procedure was
performed in 11% of the patients. At 2 years of follow up, 70% of patients with paroxys-
mal AF and 25% of patients with persistent AF were free of recurrent episodes of AF, in
the absence of antiarrhythmic drug therapy (p<0.001). Among patients with paroxysmal
AF, vagotonic AF was the only independent predictor of recurrent AF. Complications con-
sisted of pericardial tamponade (0.5%), left atrial flutter (0.5%), transient ischemic attack
(0.5%), and unilateral quadrantopsia (0.5%). No patient had symptomatic pulmonary vein
stenosis. Conclusions: The long-term efficacy of pulmonary vein isolation is 70% in
patients with paroxysmal AF, and the risk of complications is low. Alternative ablation
strategies should be considered to improve long-term efficacy, particularly in patients
with persistent or vagotonic AF.
Inappropriate Therapy
Type Frequency
AF 131 (48%)
Other SVT 96 (34 %)
Abnormal Sensing 48 (17 %)
